phrykt

Harrow, Inc. (HROW): who owns it and who trades it

As of Nov 16, 2026, HROW insiders reported 7 open-market sales worth $9.6M and 4 purchases worth $469K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Opaleye Management Inc. (10% owner), with $9.2M. 3 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Harrow

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns HROW

223 funds and institutions reported HROW shares worth $961M at the end of Q2 2026, about 63% of the company. The largest holder is BlackRock, Inc. with 7.4%.

Funds and institutions (13F) 63%Everyone else 37%

10 largest owners, by share of the company

BlackRock, Inc.7.4%
Opaleye Management Inc.6.4%
California State Teachers Retirement System4.3%
Private Capital Management, LLC4.3%
Vanguard Capital Management LLC3.8%
Deep Track Capital, LP2.6%
State Street Corp2.5%
Geode Capital Management, LLC2.4%
Bamco Inc2.2%
Dimensional Fund Advisors LP1.8%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.2.74M7.36%$116M+7%
Opaleye Management Inc.2.40M6.45%$102M-15%
California State Teachers Retirement System1.62M4.34%$38M+4039%
Private Capital Management, LLC1.60M4.29%$67.9M+2%
Vanguard Capital Management LLC1.42M3.81%$60.2M+1%
Deep Track Capital, LP969,0002.60%$41.2M–
State Street Corp939,8882.52%$39.9M+10%
Geode Capital Management, LLC905,5602.43%$38.5M+6%
Bamco Inc809,3502.17%$34.4M–
Dimensional Fund Advisors LP667,0361.79%$28.3M+15%
Jupiter Topco LLC579,1271.56%$24.6M–
Divisadero Street Capital Management, LP439,1551.18%$18.7M–
Rice Hall James & Associates, LLC387,5451.04%$16.5M+5%
Marshall Wace, LLP369,4350.99%$15.7M-43%
Citadel Advisors LLC359,8740.97%$15.3M+63%
Northern Trust Corp323,2060.87%$13.7M+9%
Schonfeld Strategic Advisors LLC319,6250.86%$13.6M–
Vanguard Portfolio Management LLC318,6100.86%$13.5M+10%
Charles Schwab Investment Management Inc273,6960.74%$11.6M+1%
Sixth Street Partners Management Company, L.P.273,6960.74%$11.6M–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, HROW insiders reported $469K of open-market purchases and $9.6M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$469K
4 trades, 4 people
Sales, 12 months
$9.6M
7 trades, 2 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Aug 14, 2026
Filed Aug 17, 2026

Purchases and sales by month

$7.8M$7.8MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 14, 2026Amir ShojaeiCHIEF SCIENTIFIC OFFICERSale11,250$40.00$450KForm 4
May 18, 2026Adrienne L GravesDirectorPurchase1,000$31.07$31.1KForm 4
May 18, 2026Lauren P SilvernailDirectorPurchase1,000$31.00$31KForm 4
May 14, 2026Mark L BaumCEOPurchase10,000$30.20$302KForm 4
May 14, 2026Andrew R. BollCFOPurchase3,500$29.90$105KForm 4
Mar 4, 2026Opaleye Management Inc.10% ownerSale134,000$39.67$5.3MForm 4
Mar 4, 2026Opaleye Management Inc.10% ownerSale4,263$39.67$169KForm 4
Mar 3, 2026Opaleye Management Inc.10% ownerSale1,309$39.15$51.2KForm 4
Mar 3, 2026Opaleye Management Inc.10% ownerSale59,000$39.15$2.3MForm 4
Feb 27, 2026Opaleye Management Inc.10% ownerSale5,000$54.18$271KForm 4
Jan 6, 2026Opaleye Management Inc.10% ownerSale20,000$53.35$1.1MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Opaleye Management Inc.10% owner–$9.2MMar 4, 2026
Amir ShojaeiCHIEF SCIENTIFIC OFFICER–$450KAug 14, 2026
Mark L BaumCHIEF EXECUTIVE OFFICER, Director$302K–May 14, 2026
Andrew R. BollPRESIDENT AND CFO$105K–May 14, 2026
Adrienne L GravesDirector$31.1K–May 18, 2026
Lauren P SilvernailDirector$31K–May 18, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

HROW short interest

High short interest. 18.9% of HROW shares are sold short: about 1 share in 5. Over the last 12 reports the number of shares short went up 9%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 7.09M HROW shares were sold short, 18.9% of the shares outstanding, down 5.1% from the report before. At the average daily volume of 502,072 shares, buying them all back would take about 14.1 trading days (days to cover).

Shares short, % of all shares

18.9%May 15Oct 3021.3%

Days to cover

14.1May 15Oct 3017.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20267.09M18.92%-5%502,07214.1
Oct 15, 20267.47M19.94%-4%665,53511.2
Sep 30, 20267.76M20.71%+4%626,92712.4
Sep 15, 20267.49M19.98%+10%477,52315.7
Aug 31, 20266.78M18.08%+7%495,12513.7
Aug 14, 20266.36M16.96%-6%616,83610.3
Jul 31, 20266.78M18.22%-1%576,30711.8
Jul 15, 20266.84M18.38%-4%542,21712.6
Jun 30, 20267.15M19.20%-2%922,0497.8
Jun 15, 20267.31M19.63%+9%737,7039.9
May 29, 20266.69M17.97%+3%795,5908.4
May 15, 20266.49M17.44%+0%1.25M5.2

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Harrow company events

Harrow filed 15 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 9, 2026.

  1. Nov 9, 2026ResultsReleased financial results. Filing
  2. Oct 5, 2026DealPursuant to the Purchase Agreement, the Company agreed to acquire rights to TYRVAYA in all countries of the world other than Japan. Filing
  3. Sep 4, 2026LeadershipRandall E. Pollard ceased serving as Chief Accounting Officer and principal accounting officer of Harrow, Inc. Filing
  4. Aug 10, 2026ResultsReleased financial results. Filing
  5. Aug 6, 2026AgreementHarrow, Inc. entered into an Asset Purchase Agreement with Viatris Inc., pursuant to which the Company agreed to acquire the global rights to TYRVAYA® (varenicline solution) nasal spray 0.03 mg, a cholinergic agonist indicated for the treatment of the signs and symptoms of dry eye disease. Filing
  6. Jun 22, 2026VoteReported shareholder vote results. Filing
  7. Jun 3, 2026AnnouncementShared information with investors. Filing
  8. May 11, 2026ResultsReleased financial results. Filing
  9. Mar 27, 2026AgreementHarrow, Inc. entered into a purchase agreement, dated March 24, 2026 with BTIG, LLC, as representative of the several initial purchasers named therein, in connection with its offer and sale of $50.0 million of additional 8.625% Senior Notes due 2030. Filing
  10. Mar 24, 2026AnnouncementHarrow, Inc. issued a press release announcing the pricing of its offering of $50.0 million of additional 8.625% Senior Notes due 2030 in a private offering to persons reasonably believed to be “qualified institutional buyers” in the United States, as defined in Rule 144A under the Securities Act… Filing
  11. Mar 24, 2026AnnouncementHarrow, Inc. issued a press release to announce the launch of its offer to sell $50.0 million of additional 8.625% Senior Notes due 2030 in a private offering to persons reasonably believed to be “qualified institutional buyers” in the United States, as defined in Rule 144A under the Securities Act… Filing
  12. Mar 10, 2026AnnouncementShared information with investors. Filing
  13. Mar 2, 2026ResultsReleased financial results. Filing
  14. Feb 2, 2026LeadershipThe Company appointed Patrick W. Sullivan, age 50, as Chief Commercial Officer of the Company, effective immediately. Filing
  15. Nov 18, 2025DealHarrow, Inc. completed the previously announced acquisition of Melt Pharmaceuticals, Inc. pursuant to the Agreement and Plan of Merger, dated September 24, 2025, by and among the Company, Harrow Acquisition Sub, Inc., Melt, and the stockholder representative. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Harrow financials

Famous investors that hold HROW

3 of the 50 well-known investors we track reported holding HROW in their latest 13F filing. The largest position is Ken Griffin's, worth $16M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026520,863$16M0.0%+45%
Jim Simons · Renaissance TechnologiesQ3 202628,517$878K0.0%-36%
George Soros · Soros Fund ManagementQ3 202620,213$623K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named HROW in the last 120 days.

FiledHolderFormStake
Nov 12, 2026Daniel Kaufman13G/A7.7%
Nov 12, 2026Daniel Kaufman13G/A7.7%
Nov 6, 2026Opaleye Management Inc.13G/A5.6%
Nov 6, 2026Opaleye Management Inc.13G/A5.6%
Oct 27, 2026BlackRock, Inc.13G/A7.4%
Oct 27, 2026BlackRock, Inc.13G/A7.4%

Questions about Harrow, Inc. (HROW) stock

Who owns the most HROW stock?

The largest reported owner of Harrow, Inc. (HROW) is BlackRock, Inc., with 7.4% of the company. In total, 223 funds and institutions reported holding HROW at the end of Q2 2026, together about 63% of the shares. See the largest owners.

Are HROW insiders buying or selling?

In the last 12 months, HROW insiders reported 4 open-market purchases worth $469K and 7 sales worth $9.6M. The latest trade was on Aug 14, 2026. See every trade.

What is the short interest in HROW?

As of Oct 30, 2026, 7.09M HROW shares were sold short, 18.9% of the shares outstanding, down 5.1% from the report before. At the average daily volume of 502,072 shares, buying them all back would take about 14.1 trading days (days to cover). See the history.

Which famous investors hold HROW?

3 of the 50 well-known investors we track reported HROW in their latest 13F filing, including Ken Griffin, Jim Simons, George Soros. The largest position is worth $16M. See all holders.

Executive pay

Harrow's chief executive was paid a total of $23.6M for the year ended Dec 31, 2025, up 1638% from $1.4M the year before. In the last 12 months, Harrow's executives and directors bought $469K of stock on the open market and sold $450K.

Chief executive, total pay$23.6MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$33.1MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$3.6MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.